From 18 to 20 March 2026, the International Haemovigilance Network (IHN) Symposium was held at the Hotel Quirinale in Rome.
This biennial event, organised by the IHN in collaboration with the National Blood Centre (Centro Nazionale Sangue), represents the leading international meeting in the field of haemovigilance. It brought together experts from around the world to share knowledge and engage in discussion on all aspects of blood safety and haemovigilance.
For further info:
Programme
Day 1 presentations:
1.P. M. Placanica – The National System for Sentinel Event Reporting (SIMES)
1_PLACANICA
2.G. Forni – Supply of components for patients with haemoglobinopathies
2_FORNI
3.S. Vaglio – Haemoglobinopathies and thalassemia registry
3_VAGLIO
4.G. De Silvestro – Clinical implications of the Italian national register of therapeutic apheresis
4_DE_SILVESTRO
5.E. Petrisli – WHO NOTIFY 15 Year Anniversary
4_PETRISLI
6.I.Pati-V.Piccinini – Italian perspective on Haemovigilance and epidemiological surveillance
6_PATI_PICCININI
7.P.F. Toledo Barbosa – The Brazilian haemovigilance system
7_TOLEDO BARBOSA
8.I. Seferi – The Albanian haemovigilance system: Challenges and opportunities
8_SEFERI
10.C. Mikkelsen – Precision donor health: The future of donor vigilance?
10_MIKKELSEN
11.V. McDonald – Cyber security Case Study
11_MCDONALD
12.R. Goel – Haemovigilance and AI
12_GOEL
Day 2 presentations:
1.M. Haugen – The effect of plasma donation frequency on donor health and IgG levels
1_HAUGEN
2.V. Agostini – Delayed haemolytic transfusion reactions
2_AGOSTINI
3.D. Martino – From donation to lifelong treatment: Late but critical risks of transfusion and plasma-derived therapies from the patient perspective
3_MARTINO
4.S.Brujins – Adverse reactions in donors
4_BRUIJNS
5.M. Claus – Vigilance in the new SoHO Regulation: Regulatory obligations for the actors involved
5_CLAUS
6.R.M. Grubovic Rastvorceva – EDQM: Role and targeted activities
6_GRUBOVIC RASTVORCEVA
7.F.X. Lamy – ECDC: Role and targeted activities
7_LAMY
8.A. Kelly – Paediatric Transfusion Safety: What 10 years of SHOT haemovigilance data tells us
8_KELLY
9.L. Teofili-C. Pellegrino-S. Nobile – Neonatal transfusion: Why adult standards leave neonates behind
9_TEOFILI_PELLEGRINO_NOBILE
11.A. Agarwal – Perioperative Red Blood Cell Transfusion and Association with Postoperative Sepsis in a North American Prospective Registry: Is it a Hemovigilance Alert?
11_AGARWAL
12.A. Asante – Platelets, The Good, The Bad and The Ugly
12_ASANTE
13.M. Feltkamp – Climate change and emerging infectious diseases
13_FELTKAMP
14.O.B. Vesterager Pedersen – Environmental contaminants e.g. PFAS
14_PEDERSEN
15.A. Eder – Transfusion-transmitted Malaria and Hemovigilance in the US
15_EDER
Day 3 presentations:
1.P.C. Spinella – Increased use of LTOWB in RhD-negative women and alloimmunisation
1_SPINELLA
2.L. Green – SWIFT Trial
2_GREEN
3.M. Gybel-Brask – Freeze dried plasma in a preclinical setting – The Danish experience
3_GYBEL_BRASK
4.E. Klæboe Kristoffersen – Cold-stored platelets; the Norwegian experience
4_KRISTOFFERSEN
5.A. Oates – Just culture
5_OATES
6.E Milser – Lessons from Human Factors and Ergonomics Principles in Transfusion IT
6_MILSER
7.V. Rosa – Tracing blood transfusion: Findings from the global survey
7_ROSA